Syneos Health, Inc.
|Company Name||Syneos Health, Inc.|
On February 27, 2019, Syneos disclosed that the Securities and Exchange Commission (“SEC”) commenced an investigation into the Company’s revenue accounting policies, internal controls and related matters, and requested that the Company retain certain documents for the periods beginning with January 1, 2017. On this news, Syneos’ share price fell $10.31 or 19.8%, to close at $41.70 per share on February 28, 2019, thereby injuring investors.
Submit Your Information
If you suffered a loss on your Syneos Health, Inc. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below.
An attorney will contact you at no cost to provide you information about joining the action and answer your questions. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.